Effectiveness of an active behavioural physiotherapy intervention in patients with chronic non-specific neck pain

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230429001

Enrollment

120

Registered

2023-04-29

Start date

2023-08-11

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic non-specific neck pain Neck pain, clinical trial

Interventions

The ABPI has been developed through a systematic review, a modified Delphi study internationally, use of social cognitive theory focusing on self-efficacy enhancement and has been tested in patients w

Experimental Behavioral,Active Comparator Other

Active Behavioural Physiotherapy Intervention (ABPI),Standard physiotherapy intervention (SPI)

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Participants aged 20-70 years presenting with non-specific neck pain at least 12 weeks

Exclusion criteria

Exclusion criteria: Signs and symptoms WAD or traumatic neck pain,(92) upper cervical instability, cervical artery dysfunction, suspected serious spinal pathology, active inflammatory arthritis, tumours, infection of the skin and soft tissue, bleeding disorders or using anti-coagulant medication, any current or previous treatment from any other third party, or presenting with any serious injuries, history of cervical surgery, neurological conditions, alcohol abuse, dementia, serious mental diseases, psychiatric diseases, osteoporosis, serious medical conditions (e.g. severe diabetes and hypertension), pregnant and/or non-Thai speaking and reading.

Design outcomes

Primary

Measure	Time frame
Neck Disability Index 2 (baseline and 3-month follow-up post baseline) questionnaire	—

Secondary

Measure	Time frame
Numerical Pain Rating Scale 2 (baseline and 3-month follow-up post baseline) questionnaire,Cervical Range of Motion 2 (baseline and 3-month follow-up post baseline) Cervical Range of Motion Device,Fear-Avoidance Beliefs Questionnaire 2 (baseline and 3-month follow-up post baseline) questionnaire,Central Sensitisation Inventory 2 (baseline and 3-month follow-up post baseline) questionnaire,Short Form-36 2 (baseline and 3-month follow-up post baseline) questionnaire	—

Measure

Time frame

Numerical Pain Rating Scale 2 (baseline and 3-month follow-up post baseline) questionnaire,Cervical Range of Motion 2 (baseline and 3-month follow-up post baseline) Cervical Range of Motion Device,Fear-Avoidance Beliefs Questionnaire 2 (baseline and 3-month follow-up post baseline) questionnaire,Central Sensitisation Inventory 2 (baseline and 3-month follow-up post baseline) questionnaire,Short Form-36 2 (baseline and 3-month follow-up post baseline) questionnaire

—

Countries

Thailand

Contacts

Public ContactTaweewat Wiangkham

Faculty of Allied Health Sciences, Naresuan university

taweewatw@nu.ac.th0908918669

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026